Genomics

Dataset Information

0

Comprehensive mass spectrometry screening-derived atlas of HDAC inhibitors reveals histone specific acetylation changes [ChIP-seq]


ABSTRACT: Histone deacetylases inhibitors (HDACi) have emerged as valuable therapeutics in cancer and other diseases, yet their effect on histone post-translational modification remains incompletely characterized. Here, we applied quantitative mass spectrometry and high throughput sequencing to systematically profile site-specific histone modification changes in response to a panel of HDAC inhibitors. This platform enabled mapping of histone modification changes across hundreds of sites including low abundant histone marks. Furthermore, integrative analysis of ChIP-seq and RNA-seq identified genome wide binding site for a low-abundant histone mark H2A.Z acetylation in HeLa cells and MDA-MB-231 breast cancer cells, highlighting the role of H2A.Z acetylation in regulating gene expression through various biological pathways and specific genes involved in tumor suppressor pathways. Our findings provide a functional resource for identification and quantification of epigenetic changes and transcriptional regulation of histone H2A.Z acetylation upon pharmacological perturbation

ORGANISM(S): Homo sapiens

PROVIDER: GSE308263 | GEO | 2026/03/18

REPOSITORIES: GEO

Dataset's files

Source:
Action DRS
Other
Items per page:
1 - 1 of 1

Similar Datasets

2026-03-18 | GSE308262 | GEO
2018-08-27 | PXD010424 | Pride
| PRJNA1329324 | ENA
2012-07-19 | E-GEOD-39237 | biostudies-arrayexpress
2013-04-15 | E-GEOD-43935 | biostudies-arrayexpress
| PRJNA1329323 | ENA
2020-03-24 | PXD014452 | Pride
2025-05-20 | GSE297261 | GEO
2025-05-24 | GSE297582 | GEO
2014-02-23 | E-GEOD-54910 | biostudies-arrayexpress